A novel role for VEGF-B in motorneuron degeneration in ALS

Diether Lambrechts; Peggy Lafuste; Désiré Collen; Mieke Dewerchin; Lieve Moons; Peter Carmeliet

Related publications

Article2008

Novel Role for Vascular Endothelial Growth Factor (VEGF) Receptor-1 and Its Ligand VEGF-B in Motor Neuron Degeneration

Koen Poesen, Diether Lambrechts, Philip Van Damme, Joke Dhondt, Florian L. P. Bender, Nicolas Frank, Elke Bogaert, Bart Claes, Line Heylen, An Verheyen, Katrien Raes, Marc Tjwa, Ulf Eriksson, Masabumi Shibuya, Rony Nuydens, Ludo Van Den Bosch, Theo Meert, Rudi D’Hooge, Michael Sendtner, Wim Robberecht, Peter Carmeliet

Article2004

VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS?

Diether Lambrechts, Erik Storkebaum, Peter Carmeliet

Article2004

Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS

Erik Storkebaum, Diether Lambrechts, Mieke Dewerchin, Paz Moreno-Murciano, Saskia Appelmans, Hideyasu Oh, Philip Van Damme, Bart P. F. Rutten, W.Y. Man, Maria De Mol, Sabine Wyns, David Manka, Kristel Vermeulen, Ludo Van Den Bosch, Nico Mertens, Christoph Schmitz, Wim Robberecht, Edward M. Conway, D Collen, Lieve Moons, Peter Carmeliet

Article2005

Blood flow deficits due to perivascular nerve degeneration: a novel mechanism of ALS

Erik Storkebaum, Greetje Vanhoutte, Hideki Wada, Diether Lambrechts, Gerardus M.J. Janssen, Rayna J. Gonzales, G. E. Fazzi, Masanori Morimoto, Paul Schiffers, Désiré Collen, Dylan Krause, Annemie Van der Linden, Lieve Moons, Jo G. R. De Mey, Peter Carmeliet

Article2004

Treatment of an aggressive form of motor neuron degeneration by VEGF protein and gene transfer in ALS animal models

Erik Storkebaum, Diether Lambrechts, Nebojša Arsić, Mieke Dewerchin, Philip Van Damme, Ludo Van Den Bosch, Wim Robberecht, Myriam Baes, Désiré Collen, Mauro Giacca, Lieve Moons, Peter Carmeliet

A novel role for VEGF-B in motorneuron degeneration in ALS

Discussion(0)

Related publications

Novel Role for Vascular Endothelial Growth Factor (VEGF) Receptor-1 and Its Ligand VEGF-B in Motor Neuron Degeneration

VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS?

Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS

Blood flow deficits due to perivascular nerve degeneration: a novel mechanism of ALS

Treatment of an aggressive form of motor neuron degeneration by VEGF protein and gene transfer in ALS animal models